← All patents

US20250273344A1

Methods for the detection and treatment of lung cancer

University of Texas System

Abstract

A 3-marker metabolite panel (3MetP) comprising or consisting of diacetylspermine, arginine, and creatine riboside, optionally in combination with other panels and/or models, wherein the elevated levels and/or model score classify the patient as having lung cancer, for improved risk stratification …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Samir Hanash
Priority date
November 17, 2022
Filing date
May 13, 2025
Publication date
August 28, 2025
Language
en
Metadata fetched
August 29, 2026 00:34